Page last updated: 2024-09-04

tx 3301 and Ischemia

tx 3301 has been researched along with Ischemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atar, OD; Booze, C; Eisert, C; Hanley, D; Sabaeva, E; Serebruany, V1
Bergmann, SR1

Trials

1 trial(s) available for tx 3301 and Ischemia

ArticleYear
Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation.
    Thrombosis and haemostasis, 2009, Volume: 102, Issue:3

    Topics: Aged; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Platelets; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Erythrocytes; Female; Humans; Ischemia; Leukocytes; Male; Middle Aged; Risk Factors; Spectrometry, Fluorescence; Stroke; Time Factors; Treatment Outcome

2009

Other Studies

1 other study(ies) available for tx 3301 and Ischemia

ArticleYear
Aggrenox and stress testing.
    Circulation, 2001, Feb-27, Volume: 103, Issue:8

    Topics: Adenosine; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Humans; Ischemia; Platelet Aggregation Inhibitors; Stroke; Vasodilator Agents

2001